Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.
Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a consolidated Locations section listing all study sites by state and country. Removed the individual state location subsections (e.g., Alabama Locations) and the HHS Vulnerability Disclosure link.SummaryDifference2%
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision has been updated to v3.3.2, replacing the previous v3.3.1 entry.SummaryDifference0.0%
- Check39 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0 as an administrative update; no substantive changes to study content, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check46 days agoChange DetectedRemoved the funding-disclaimer banner about potential delays and outdated information. This is an administrative change that does not alter the study details, enrollment, or outcomes.SummaryDifference0.2%
- Check61 days agoChange DetectedNo additions or deletions were detected on the page; the study details and eligibility criteria remain as published.SummaryDifference0.3%
- Check89 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference3%
Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.